The role of myocarditis-like 'hot-phase' episodes in arrhythmogenic cardiomyopathy progression and risk stratification remains unclear, though a specific gene accounts for the majority of cases.
Answers are grounded in this paper and cite their sources.
Supports prioritizing the predominant gene in testing; leaves open hot-phase episodes for progression and arrhythmic risk stratification.
is the most common disease gene, accounting for 69% of cases. Currently, the role of "hot-phase" episodes in disease progression and arrhythmic risk stratification remains to be clarified.
No takes yet. Share an insight, caveat, or question.
Bariani et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: